fda warning letters glp-1 compounders september 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading pharmaceutical ads FDA Issues Warnings Against Illegal

Convenient & Easy: Simply dissolve and enjoy

The peptide is suspected to target ghrelin receptors in the anterior pituitary gland, also known as Growth Hormone Secretagogue Receptors 1 Alpha (GHS-R1a)

Combined result: A patient paying $300 /month at Shoppers Drug Mart could bring their cost down to roughly $245 /month through steps 1 and 2 alone

The compound is not scheduled under the Controlled Substances Act and is not explicitly banned but it also lacks FDA approval and has no place on the 503A Bulk Drug Substances List, which is the only pathway for licensed compounding pharmacies to legally dispense it

Weeks 5-12 (dose escalation)

read more 8:0:10 2026-07-25 The Alarm of All Creatures on the Night of th